The effect of trimetazidine on cardiac haemodynamics and mitochondrial function in wild‐type transthyretin amyloidosis

Abstract Aims Wild‐type transthyretin cardiac amyloidosis (ATTRwt) is a cardiomyopathy causing myocardial hypoperfusion and impaired cardiac mitochondrial function. Trimetazidine is an antianginal agent used in patients with stable angina pectoris, which improves cardiac contractility and mitochondr...

Full description

Bibliographic Details
Published in:	ESC Heart Failure
Main Authors:	Bertil Thyrsted Ladefoged, Anders Lehmann Dahl Pedersen, Anne Mette Dybro, Tor Skibsted Clemmensen, Julian Gillmore, Steen Hvitfeldt Poulsen
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Subjects:	cardiac amyloidosis high‐resolution respirometry invasive haemodynamics mitochondrial oxidative phosphorylation transthyretin amyloidosis trimetazidine
Online Access:	https://doi.org/10.1002/ehf2.15181

Similar Items

Incidence and predictors of worsening heart failure in patients with wild‐type transthyretin cardiac amyloidosis
by: Bertil Thyrsted Ladefoged, et al.
Published: (2022-10-01)

Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis
by: Monika Gawor, et al.
Published: (2022-12-01)

Transthyretin Gene Variants and Associated Phenotypes in Danish Patients with Amyloid Cardiomyopathy
by: Torsten B. Rasmussen, et al.
Published: (2022-01-01)

Exercise Hemodynamics and Mitochondrial Oxidative Capacity in Disease Stages of Wild‐Type Transthyretin Amyloid Cardiomyopathy
by: Bertil Ladefoged, et al.
Published: (2024-07-01)

Proteomic Analysis of Serum in Cardiac Transthyretin Amyloidosis: Diagnostic and Prognostic Implications for Biomarker Discovery
by: Joanna Waś, et al.
Published: (2025-07-01)

A rare presentation of pulmonary transthyretin amyloidosis
by: Marc Assaad, et al.
Published: (2025-01-01)

Hereditary systemic transthyretin amyloidosis: a clinical case and an opinion on the problem
by: A. S. Draganova, et al.
Published: (2019-07-01)

Clinical case of hereditary transthyretin amyloidosis
by: N. Spasova, et al.
Published: (2024-12-01)

Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy
by: Mariana Gospodinova, et al.
Published: (2020-07-01)

Transthyretin Amyloidosis Therapies: Guiding the Future
by: Alejandra González-Duarte
Published: (2021-01-01)

Vutrisiran in Transthyretin Amyloidosis
by: Ronald M. Witteles, MD, et al.
Published: (2025-09-01)

Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real‐World Data
by: Maximilian Leo Müller, et al.
Published: (2024-07-01)

Clinical and genetic profiles of patients with hereditary and wild-type transthyretin amyloidosis: the Transthyretin Cardiac Amyloidosis Registry in the state of São Paulo, Brazil (REACT-SP)
by: Fábio Fernandes, et al.
Published: (2024-07-01)

Changes of clinical characteristics, distribution of red flags and prognosis in contemporary patients with wild-type transthyretin amyloidosis cardiomyopathy
by: Larsen Sanne Bøjet, et al.
Published: (2024-12-01)

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
by: Hiroyuki Yamamoto, et al.
Published: (2018-12-01)

Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy
by: S. S. Nikitin, et al.
Published: (2021-12-01)

A Comparative Study of the Electroneurographic Findings in Amyloidotic Polyneuropathy in Patients with Light-Chain Amyloidosis and Glu54Gln Transthyretin Amyloidosis
by: Mirela Drăghici, et al.
Published: (2024-12-01)

A Clinical Case of the Hereditary Transthyretin Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-05-01)

Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report
by: Benjamin Terrier, et al.
Published: (2017-08-01)

Efficacy and safety of diflunisal therapy in patients with transthyretin cardiac amyloidosis (ATTR-CA): a systematic review and meta-analysis
by: Wilbert Huang, et al.
Published: (2025-03-01)

Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis
by: Inmaculada Moreno-Gázquez, et al.
Published: (2023-10-01)

Hereditary transthyretin amyloidosis incidentally diagnosed by video-associated lung surgery for lung cancer: A case report
by: Katsuhiro Itogawa, et al.
Published: (2025-01-01)

A clinical case of transthyretin amyloidosis with manifestations of seronegative arthritis
by: V. A. Mareeva, et al.
Published: (2024-02-01)

Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
by: Hiroaki Matsushita, et al.
Published: (2022-06-01)

Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis
by: Richard K. Cheng, et al.
Published: (2021-12-01)

Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure
by: Gabriela Molina O, et al.
Published: (2014-11-01)

Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications
by: Giedre Balciunaite, et al.
Published: (2020-03-01)

The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
by: Francesco Bemporad, et al.
Published: (2022-02-01)

Oxidative Stress in Transthyretin-Mediated Amyloidosis: An Exploratory Study
by: Marco Fiore, et al.
Published: (2024-08-01)

Unraveling gut microbiome alterations and metabolic signatures in hereditary transthyretin amyloidosis
by: Hanyu Li, et al.
Published: (2025-07-01)

Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy
by: Ana Devesa, et al.
Published: (2021-08-01)

Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01)

Hereditary and wild type transthyretin amyloid cardiomyopathy in Bulgaria in patients suspected for cardiac amyloidosis
by: S. Stefanov, et al.
Published: (2024-09-01)

Kidney, the Cinderella Story of Transthyretin Amyloidosis
by: Nelson Leung
Published: (2025-06-01)

Leptomeningeal amyloidosis: features of the clinical picture (clinical observation)
by: E. I. Safiulina, et al.
Published: (2022-12-01)

Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients
by: Rana Hassan, et al.
Published: (2023-03-01)

Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
by: Juan González-Moreno, et al.
Published: (2023-12-01)

Potential use of cardiac magnetic resonance imaging in differential diagnosis of cardiomyopathies due to light-chain amyloidosis and transthyretin amyloidosis
by: Zainab M. Magomedova, et al.
Published: (2024-01-01)

Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review
by: Maria Papathanasiou, et al.
Published: (2021-12-01)

Update of Natural Compounds in Transthyretin Amyloidosis, Years 2020–2025
by: Carlo Marotta, et al.
Published: (2025-07-01)